Form 4: Sight Sciences Chief Legal Officer Jeremy Hayden Receives Stock Grant

Jeremy Hayden, Chief Legal Officer of Sight Sciences, Inc., was granted 139,785 restricted stock units (RSUs) on March 11, 2025, under the company's 2021 Incentive Award Plan.

Summary

• On March 11, 2025, Jeremy Hayden, the Chief Legal Officer of Sight Sciences, Inc., received a grant of 139,785 restricted stock units (RSUs).
• These RSUs were granted under the company's 2021 Incentive Award Plan.
• The RSUs will vest in 16 equal quarterly installments, starting on March 31, 2025, and continuing until December 31, 2028, contingent upon Mr. Hayden's continued service to the company.
• Each RSU represents the right to receive one share of Sight Sciences' common stock.
• The number of RSUs granted was determined by dividing $390,000 by the closing price of the common stock on the grant date.
• The RSUs have no expiration date.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The grant of RSUs is a standard practice and indicates confidence in the executive and the company's future. The vesting schedule promotes long-term alignment.

Positives

• The grant of RSUs aligns the executive's interests with those of the shareholders, incentivizing continued service and contribution to the company's success.
• The vesting schedule encourages long-term commitment from the Chief Legal Officer.

Risks

• The value of the RSUs is dependent on the future performance of Sight Sciences' stock, which is subject to market risks.
• If Jeremy Hayden leaves the company before the RSUs fully vest, he will forfeit the unvested portion.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the RSUs.

Industry Context

Stock grants are a common form of executive compensation in the technology and healthcare industries, aligning management's interests with shareholder value creation. The vesting schedule is typical for such grants.

Comparison to Industry Standards

• Stock grants are a standard component of executive compensation packages in publicly traded companies, particularly in the tech and biotech sectors.
• Companies like Alcon, Johnson & Johnson, and Bausch + Lomb also utilize stock-based compensation to incentivize their executives.
• The vesting schedule of 16 quarterly installments over four years is a common practice, similar to what is seen at companies like Google (Alphabet) and Microsoft.

Stakeholder Impact

• Shareholders may view the RSU grant positively as it aligns management's interests with long-term value creation.
• Employees may see the grant as a sign of the company's commitment to its leadership team.

Key Dates